VANCOUVER, British Columbia, March 21, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that Neil Belot has been promoted to Chief Global Business Development Officer.
Mr. Belot has held the position of Chief Brand Officer at Aurora since 2015, pre-sales license, with operational oversight of brand, sales, marketing, client care, and digital technology. In his new role, he will focus on developing business opportunities that drive the Company’s international growth.
Mr. Belot has been deeply involved with Canada’s medical cannabis industry and community for more than seven years under three different federal sets of regulations known as the MMAR, MMPR and the ACMPR. Prior to joining Aurora, Mr. Belot was the Executive Director of the trade association for commercial licensed producers known as the Canadian Medical Cannabis Industry Association. He earned an international finance-focused MBA while studying at Dalhousie University and Copenhagen Business School. Before joining the industry association he managed one of Canada’s largest programs for the legislated bulk trading, pricing, hedging, transporting, and supply of energy to a portfolio of over 40 municipal corporate clients with over 15,000 points of distribution.
“Neil’s unique talents and exceptional leadership have helped Aurora swiftly establish itself as one of the most respected cannabis companies in Canada. We are thrilled to have him leading our global business development, as federally regulated cannabis markets evolve and expand both here at home and around the world,” said Terry Booth, CEO.
Aurora’s wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, and is currently constructing a second 800,000 square foot production facility, known as “Aurora Sky”, at the Edmonton International Airport. The Aurora Sky project has secured advanced technology from the most renowned design and construction suppliers in the Netherlands. Aurora’s common shares trade on the TSX-V under the symbol “ACB”.
On behalf of the Board of Directors,
AURORA CANNABIS INC.
This news release contains certain “forward-looking statements” within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. There is no assurance that the Proposal will be completed on the terms or within the timeframe contemplated in this news release or at all. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Executive Vice President